Chevron director Hess exercises options, sells stock
Chevron Corp director John B. Hess reported a series of equity transactions on August 3, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Chevron Corp director John B. Hess reported a series of equity transactions on August 3, 2026. He exercised non-qualified stock options into 709,362 shares of common stock and associated entities sold 810,665 shares. He also reported restructuring moves totaling 2,701,503 shares, including a pro rata distribution from a limited partnership and transfers involving family trusts and a direct account.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (Right to Buy) F18 | 170,077 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (Right to Buy) F19 | 243,706 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (Right to Buy) F20 | 117,498 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (Right to Buy) F21 | 103,771 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (Right to Buy) F22 | 74,310 | $0.00 | $0.00 |
| Sale | Common Stock F1, F2 | 55,510 | $194.0703 | $10.77M |
| Sale | Common Stock F3, F2 | 44,490 | $194.4974 | $8.65M |
| Other | Common Stock F4, F5 | 2,244,497 | $0.00 | $0.00 |
| Other | Common Stock F4, F6 | 9,118 | $0.00 | $0.00 |
| Other | Common Stock F4, F7 | 439,786 | $0.00 | $0.00 |
| Other | Common Stock F4, F8 | 8,102 | $0.00 | $0.00 |
| Exercise | Common Stock | 170,077 | $55.36 | $9.42M |
| Exercise | Common Stock | 243,706 | $48.51 | $11.82M |
| Exercise | Common Stock | 117,498 | $73.21 | $8.60M |
| Exercise | Common Stock | 103,771 | $98.71 | $10.24M |
| Exercise | Common Stock | 74,310 | $138.10 | $10.26M |
| Sale | Common Stock F9 | 174,821 | $194.4221 | $33.99M |
| Sale | Common Stock F10 | 25,179 | $195.2772 | $4.92M |
| Sale | Common Stock F11 | 90,031 | $192.7486 | $17.35M |
| Sale | Common Stock F12 | 118,657 | $193.2886 | $22.94M |
| Sale | Common Stock F13 | 271,946 | $194.4805 | $52.89M |
| Sale | Common Stock F14, F15 | 30,031 | $195.1371 | $5.86M |
| Holding | Common Stock F16 | -- | -- | -- |
| Holding | Common Stock F17 | -- | -- | -- |
Footnotes (22)
- F1. These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.
- F2. Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.
- F3. These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.
- F4. Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.
- F5. Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.
- F6. Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.
- F7. Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.
- F8. This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.
- F9. These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.
- F10. These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.
- F11. These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.
- F12. These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.
- F13. These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.
- F14. These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.
- F15. Total includes the sale of 1,303 shares directly held.
- F16. Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.
- F17. Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.
- F18. Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.
- F19. Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.
- F20. Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.
- F21. Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.
- F22. Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.
Key Figures
Key Terms
Non-Qualified Stock Option financial
weighted average sale price financial
pro rata distribution financial
beneficial ownership financial
Non-Employee Directors' Equity Compensation and Deferral Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did John B. Hess report in this Form 4 for Chevron (CVX)?
How many Chevron (CVX) stock options did John B. Hess exercise?
AI-generated analysis. How Rhea-AI works. Not financial advice.